登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Supplementary Table 2 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1
Supplementary Table 2 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1
收藏
Figshare
2023-03-01 更新
2026-04-28 收录
肿瘤免疫联合疗法
黑色素瘤研究
数据链接:
https://figshare.com/articles/dataset/Supplementary_Table_2_from_Phase_I_Study_of_Androgen_Deprivation_Therapy_in_Combination_with_Anti_PD-1_in_Melanoma_Patients_Pretreated_with_Anti_PD-1/22489796
数据链接
链接失效反馈
官方服务:
问题咨询
购买咨询
在线客服
NEW
资源简介:
Previous therapies and outcome
应用场景:
创建时间:
2023-03-01
相关数据集
Patient 1 - Melanoma with precursor fields
黑色素瘤研究
医学图像分析
t-CyCIF analysis of biopsy from Patient 1 that contains examplars of early melanoma progression.
DataCite Commons
2025-05-12 更新
13
0
Supplementary Table 2 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1
肿瘤免疫治疗
黑色素瘤研究
Previous therapies and outcome
Figshare
2023-03-01 更新
7
0
TGF?1 treatment of A2058 melanoma cells
黑色素瘤研究
TGF-β信号通路
4 replicates were prepared from A2058 melanoma cells [transfected with 10ng of empty vector (pcDNA3.1+)] and treated with 5ng/ml TGFβ1 or vehicle control for 24hrs This is the control arm of a larger
NIAID Data Ecosystem
5
0
dediff_melanoma_clinical.csv
黑色素瘤研究
The clinical metadata used for figure 4 and supplemental figure 1
NIAID Data Ecosystem
8
0
Supplementary Table S1 from Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma
肿瘤免疫治疗
黑色素瘤研究
Supplementary Table S1 from Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma
NIAID Data Ecosystem
6
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广